Voyageur Pharmaceuticals Ltd.
VYYRF
$0.12
$0.002.22%
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -77.42% | -53.25% | -102.10% | -99.32% | -62.45% |
| Total Depreciation and Amortization | -20.00% | -27.27% | -33.33% | -30.77% | -28.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.78% | -36.73% | 83.02% | 69.25% | 77.46% |
| Change in Net Operating Assets | 987.55% | 212.21% | -86.91% | -95.62% | -64.61% |
| Cash from Operations | 18.34% | -56.61% | -730.20% | -638.92% | -196.03% |
| Capital Expenditure | -79.20% | -48.66% | -59.28% | -27.74% | 9.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -79.20% | -48.66% | -59.28% | -27.74% | 9.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -3.63% | 7.32% | 570.19% | 567.63% | 234.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -398.89% | -405.86% | -363.36% | 204.50% | 442.21% |
| Cash from Financing | -22.21% | -12.47% | 355.33% | 613.48% | 267.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.43% | -248.64% | -39.95% | 19,761.76% | 416.69% |